MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.acmx.2017.01.007

Медицинская библиотека · Archivos de cardiologia de Mexico · 2017

Inferior vena cava filters in pulmonary embolism: A historic controversy.

Jerjes-Sanchez Carlos, Rodriguez David, Navarrete Aline, Parra-Cantu Carolina, Joya-Harrison Jorge, Vazquez Eduardo, Ramirez-Rivera Alicia

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Rationale for non-routine use of inferior venous cava filters (IVCF) in pulmonary embolism (PE) patients.

METHODS

Thrombosis mechanisms involved with IVCF placement and removal, the blood-contacting medical device inducing clotting, and the inorganic polyphosphate in the contact activation pathway were analyzed. In addition, we analyzed clinical evidence from randomized trials, including patients with and without cancer. Furthermore, we estimated the absolute risk reduction (ARR), the relative risk reduction (RRR), and the number needed to treat (NNT) based on the results of each study using a frequency table. Finally, we analyzed the outcome of our PE patients that were submitted to thrombolysis with short and long term follow-up.

RESULTS

IVCF induces thrombosis by several mechanisms including placement and removal, rapid protein adsorption, and simultaneous surface-induced activation via the contact activation pathway. Also, inorganic polyphosphate has an important role as a procoagulant, reversing the effect of anticoagulants. Randomized control trials included 904 cancer and non-cancer PE patients. In terms of ARR, RRR, and NNT, there is no evidence for routine use of IVCF. In 290 patients with proved PE, extensive thrombotic burden and right ventricular dysfunction under thrombolysis and oral anticoagulation, we observed a favorable outcome in a short- and long-term follow-up; additionally, IVCF was only used in 5% of these patients.

CONCLUSION

Considering the complex mechanisms of thrombosis related with IVCF, the evidence from randomized control trials and ARR, RRR, and NNT obtained from venous thromboembolism patients with and without cancer, non-routine use of IVCF is recommended.

Для цитирования: Jerjes-Sanchez Carlos, Rodriguez David, Navarrete Aline, Parra-Cantu Carolina, Joya-Harrison Jorge, Vazquez Eduardo, Ramirez-Rivera Alicia. Inferior vena cava filters in pulmonary embolism: A historic controversy.. Archivos de cardiologia de Mexico. 2017. DOI: 10.1016/j.acmx.2017.01.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.